Trials / Completed
CompletedNCT01963793
Topical Aprepitant in Prurigo Patients
Topical Aprepitant in Prurigo Patients An Exploratory Phase IIa Trial With Topically Applied Aprepitant in Patients With Prurigo
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- LEO Pharma · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Topical Aprepitant in Prurigo Patients - An Exploratory Phase IIa Trial With Topically Applied Aprepitant in Patients With Prurigo
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aprepitant | Aprepitant gel (10 mg/g) |
| DRUG | Placebo | gel without active component |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2014-07-01
- Completion
- 2014-07-01
- First posted
- 2013-10-16
- Last updated
- 2025-03-10
- Results posted
- 2021-07-16
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01963793. Inclusion in this directory is not an endorsement.